393
Participants
Start Date
September 27, 2024
Primary Completion Date
December 8, 2026
Study Completion Date
August 23, 2027
GSK4532990
GSK4532990 will be administered
Placebo
Placebo will be administered
RECRUITING
GSK Investigational Site, Ansan
RECRUITING
GSK Investigational Site, Philadelphia
RECRUITING
GSK Investigational Site, Milan
RECRUITING
GSK Investigational Site, Milan
RECRUITING
GSK Investigational Site, Richmond
RECRUITING
GSK Investigational Site, León
RECRUITING
GSK Investigational Site, Bergamo
RECRUITING
GSK Investigational Site, Miami Lakes
RECRUITING
GSK Investigational Site, Brandon
RECRUITING
GSK Investigational Site, Santander
RECRUITING
GSK Investigational Site, Valencia
RECRUITING
GSK Investigational Site, Indianapolis
RECRUITING
GSK Investigational Site, Detroit
RECRUITING
GSK Investigational Site, Marrero
RECRUITING
GSK Investigational Site, San Antonio
RECRUITING
GSK Investigational Site, McAllen
RECRUITING
GSK Investigational Site, Chandler
RECRUITING
GSK Investigational Site, Los Angeles
RECRUITING
GSK Investigational Site, Terrebonne
RECRUITING
GSK Investigational Site, Chiba
WITHDRAWN
GSK Investigational Site, Kagawa
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Suwon Gyeonggi-do
RECRUITING
GSK Investigational Site, Barcelona
RECRUITING
GSK Investigational Site, Glasgow Strathclyde
RECRUITING
GSK Investigational Site, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY